Evidence map›Paper›PMID 42756115›Full record

ArticleFrontiers in psychiatry2026

Frequency analysis of mood, sleep, and alcohol and nicotine use: investigating instability in bipolar I and II disorder.

Stine Holmstul Glastad, Ole Klungsøyr, Sofie Ragnhild Aminoff, Roger Hagen, Thomas Bjella, Magnus Johan Engen, Siv Hege Lyngstad, Ingrid Melle, Ole A Andreassen, Margrethe Collier Høegh and 1 more

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stine Holmstul GlastadSection for Clinical Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Ole KlungsøyrDepartment for Research and Innovation, Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Sofie Ragnhild AminoffSection for Early Intervention in Psychosis Advisory Service, South East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Roger HagenDepartment of Psychology, University of Oslo, Oslo, Norway.
Thomas BjellaSection for Treatment Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Magnus Johan EngenNydalen District Psychiatric Centre, Division of Mental Health and Addition, Oslo University Hospital, Oslo, Norway.
Siv Hege LyngstadNydalen District Psychiatric Centre, Division of Mental Health and Addition, Oslo University Hospital, Oslo, Norway.
Ingrid MelleSection for Clinical Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Ole A AndreassenInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Margrethe Collier HøeghSection for Clinical Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Trine Vik LagerbergDepartment of Psychology, University of Oslo, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Individuals with bipolar disorder (BD) often experience unstable mood beyond mood episodes, which appears to be more prominent in BD II than in BD I. It is unclear whether the mood instability and associated sleep- and substance use patterns are different between BD subtypes and also present in the first treatment phase of the disorder. In this study, we compared the degree of instability of mood, sleep characteristics, and use of nicotine and alcohol across BD I and II. Methods: We recruited 40 patients with BD in their first treatment phase (BD I n = 15, BD II n = 22 and BD Not Otherwise Specified n = 3) at Oslo University Hospital in Norway. The "MinDag" (MyDay) app was used to collect daily self-reports of mood (sadness, irritability, mood elevation and anxiety), sleep (length and quality) and weekly reports of alcohol and nicotine use for up to six months (mean no. of weeks = 18.5, a total of up to 740 weeks). To compare the degree of instability in the time-series across the two BD subtypes we used Root Mean Squared Successive Differences (rMSSD), representing the time domain, and power spectral density (PSD), representing the frequency domain. Cumulative difference periodogram (CDP) was used for group comparison. Results: Significant differences were found between BD I and BD II in the mean levels of irritability and mean hours of sleep throughout the follow-up period. The trends for higher instability in anxiety (.029) and irritability (.058) in BD II compared to BD I did not survive Bonferroni correction. Similarly, the variability of sleep length and quality and the use of nicotine and alcohol was comparable across the two groups. Conclusion: Applying longitudinal app-based self-monitoring and time-series analyses, our study did not replicate previous findings of more mood instability in BD II versus BD I. The pattern of similar instability across the groups also applied to sleep characteristics and nicotine and alcohol use. Larger samples are needed to investigate how BD subtypes can explain the instability of mood and other illness-related features, which could support the development of more personalized treatment.

Indexed as

alcohol usebipolar disorderinstabilitymoodnicotine usesleeptime-series

Identifiers

PMID42756115
PMCPMC13582255

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.